Annual CFF
$25.55 M
-$46.38 M-64.48%
December 31, 2024
Summary
- As of March 9, 2025, BDTX annual cash flow from financing activities is $25.55 million, with the most recent change of -$46.38 million (-64.48%) on December 31, 2024.
- During the last 3 years, BDTX annual CFF has risen by +$24.82 million (+3404.39%).
- BDTX annual CFF is now -88.11% below its all-time high of $214.94 million, reached on December 31, 2020.
Performance
BDTX Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$291.00 K
+$543.00 K+215.48%
December 31, 2024
Summary
- As of March 9, 2025, BDTX quarterly cash flow from financing activities is $291.00 thousand, with the most recent change of +$543.00 thousand (+215.48%) on December 31, 2024.
- Over the past year, BDTX quarterly CFF has increased by +$337.00 thousand (+732.61%).
- BDTX quarterly CFF is now -99.86% below its all-time high of $213.84 million, reached on March 31, 2020.
Performance
BDTX Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$25.55 M
+$337.00 K+1.34%
December 31, 2024
Summary
- As of March 9, 2025, BDTX TTM cash flow from financing activities is $25.55 million, with the most recent change of +$337.00 thousand (+1.34%) on December 31, 2024.
- Over the past year, BDTX TTM CFF has dropped by -$46.38 million (-64.48%).
- BDTX TTM CFF is now -92.52% below its all-time high of $341.67 million, reached on June 30, 2020.
Performance
BDTX TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
BDTX Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -64.5% | +732.6% | -64.5% |
| 3 y3 years | +3404.4% | +100.0% | +3404.4% |
| 5 y5 years | -80.0% | -99.7% | -80.0% |
BDTX Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -64.5% | >+9999.0% | -99.6% | +215.5% | -73.8% | >+9999.0% |
| 5 y | 5-year | -88.1% | >+9999.0% | -99.9% | +215.5% | -92.5% | >+9999.0% |
| alltime | all time | -88.1% | >+9999.0% | -99.9% | +215.5% | -92.5% | >+9999.0% |
Black Diamond Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $25.55 M(-64.5%) | $291.00 K(-215.5%) | $25.55 M(+1.3%) |
| Sep 2024 | - | -$252.00 K(-101.2%) | $25.21 M(-74.1%) |
| Jun 2024 | - | $21.38 M(+417.6%) | $97.39 M(+28.1%) |
| Mar 2024 | - | $4.13 M(-9078.3%) | $76.01 M(+5.7%) |
| Dec 2023 | $71.93 M(>+9900.0%) | -$46.00 K(-100.1%) | $71.93 M(-0.0%) |
| Sep 2023 | - | $71.93 M(>+9900.0%) | $71.95 M(>+9900.0%) |
| Jun 2023 | - | $0.00(-100.0%) | $75.00 K(0.0%) |
| Mar 2023 | - | $51.00 K(-282.1%) | $75.00 K(-57.6%) |
| Dec 2022 | $177.00 K(-75.7%) | -$28.00 K(-153.8%) | $177.00 K(-13.7%) |
| Sep 2022 | - | $52.00 K(>+9900.0%) | $205.00 K(-5.5%) |
| Jun 2022 | - | $0.00(-100.0%) | $217.00 K(-45.9%) |
| Mar 2022 | - | $153.00 K(>+9900.0%) | $401.00 K(-45.0%) |
| Dec 2021 | $729.00 K | $0.00(-100.0%) | $729.00 K(-53.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | $64.00 K(-65.2%) | $1.56 M(-11.7%) |
| Jun 2021 | - | $184.00 K(-61.7%) | $1.76 M(+11.6%) |
| Mar 2021 | - | $481.00 K(-42.0%) | $1.58 M(-99.3%) |
| Dec 2020 | $214.94 M(+68.2%) | $830.00 K(+207.4%) | $214.94 M(-27.8%) |
| Sep 2020 | - | $270.00 K(>+9900.0%) | $297.61 M(-12.9%) |
| Jun 2020 | - | $0.00(-100.0%) | $341.67 M(+0.0%) |
| Mar 2020 | - | $213.84 M(+156.1%) | $341.60 M(+167.4%) |
| Dec 2019 | $127.76 M(+144.2%) | $83.50 M(+88.3%) | $127.76 M(+188.6%) |
| Sep 2019 | - | $44.33 M(<-9900.0%) | $44.26 M(<-9900.0%) |
| Jun 2019 | - | -$70.00 K(<-9900.0%) | -$70.00 K(<-9900.0%) |
| Mar 2019 | - | $0.00 | $0.00 |
| Dec 2018 | $52.31 M(+424.5%) | - | - |
| Dec 2017 | $9.97 M | - | - |
FAQ
- What is Black Diamond Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Black Diamond Therapeutics?
- What is Black Diamond Therapeutics annual CFF year-on-year change?
- What is Black Diamond Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Black Diamond Therapeutics?
- What is Black Diamond Therapeutics quarterly CFF year-on-year change?
- What is Black Diamond Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Black Diamond Therapeutics?
- What is Black Diamond Therapeutics TTM CFF year-on-year change?
What is Black Diamond Therapeutics annual cash flow from financing activities?
The current annual CFF of BDTX is $25.55 M
What is the all time high annual CFF for Black Diamond Therapeutics?
Black Diamond Therapeutics all-time high annual cash flow from financing activities is $214.94 M
What is Black Diamond Therapeutics annual CFF year-on-year change?
Over the past year, BDTX annual cash flow from financing activities has changed by -$46.38 M (-64.48%)
What is Black Diamond Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of BDTX is $291.00 K
What is the all time high quarterly CFF for Black Diamond Therapeutics?
Black Diamond Therapeutics all-time high quarterly cash flow from financing activities is $213.84 M
What is Black Diamond Therapeutics quarterly CFF year-on-year change?
Over the past year, BDTX quarterly cash flow from financing activities has changed by +$337.00 K (+732.61%)
What is Black Diamond Therapeutics TTM cash flow from financing activities?
The current TTM CFF of BDTX is $25.55 M
What is the all time high TTM CFF for Black Diamond Therapeutics?
Black Diamond Therapeutics all-time high TTM cash flow from financing activities is $341.67 M
What is Black Diamond Therapeutics TTM CFF year-on-year change?
Over the past year, BDTX TTM cash flow from financing activities has changed by -$46.38 M (-64.48%)